CID 53481210

Ganglioside gq1c (d18:0/16:0)

Structural Information

Molecular Formula
C105H181N5O55
SMILES
CCCCCCCCCCCCCCC[C@H]([C@H](CO[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O[C@H]4[C@@H]([C@H]([C@H]([C@H](O4)CO)O)O[C@@]5(C[C@@H]([C@H](C(O5)[C@@H]([C@@H](CO)O)O)NC(=O)C)O)C(=O)O)O)CC(=O)C)O[C@@]6(C[C@@H]([C@H](C(O6)[C@@H]([C@@H](CO)O[C@@]7(C[C@@H]([C@H](C(O7)[C@@H]([C@@H](CO)O[C@@]8(C[C@@H]([C@H](C(O8)[C@@H]([C@@H](CO)O)O)NC(=O)C)O)C(=O)O)O)NC(=O)C)O)C(=O)O)O)NC(=O)C)O)C(=O)O)O)O)O)NC(=O)CCCCCCCCCCCCCCC)O
InChI
InChI=1S/C105H181N5O55/c1-8-10-12-14-16-18-20-22-24-26-28-30-32-34-57(124)56(110-70(131)35-33-31-29-27-25-23-21-19-17-15-13-11-9-2)49-150-95-82(139)81(138)86(68(47-117)153-95)156-97-84(141)93(87(69(48-118)154-97)157-94-55(36-50(3)119)85(77(134)64(43-113)151-94)155-96-83(140)92(78(135)65(44-114)152-96)164-104(100(146)147)39-60(127)72(107-52(5)121)89(161-104)76(133)63(130)42-112)165-105(101(148)149)40-61(128)74(109-54(7)123)91(163-105)80(137)67(46-116)159-103(99(144)145)38-59(126)73(108-53(6)122)90(162-103)79(136)66(45-115)158-102(98(142)143)37-58(125)71(106-51(4)120)88(160-102)75(132)62(129)41-111/h55-69,71-97,111-118,124-130,132-141H,8-49H2,1-7H3,(H,106,120)(H,107,121)(H,108,122)(H,109,123)(H,110,131)(H,142,143)(H,144,145)(H,146,147)(H,148,149)/t55-,56+,57-,58+,59+,60+,61+,62-,63-,64-,65-,66-,67-,68-,69-,71-,72-,73-,74-,75-,76-,77+,78+,79-,80-,81-,82-,83-,84-,85-,86-,87+,88?,89?,90?,91?,92+,93-,94+,95-,96+,97+,102-,103-,104+,105+/m1/s1
InChIKey
JGBVSNZOIAPDIV-IZZPKBJDSA-N
Compound name
(2S,4S,5R)-5-acetamido-2-[(2R,3R,4S,5S,6R)-2-[(2S,3R,4R,5R,6R)-2-[(2R,3S,4R,5R,6S)-4-[(2S,4S,5R)-5-acetamido-6-[(1S,2R)-2-[(2S,4S,5R)-5-acetamido-6-[(1S,2R)-2-[(2S,4S,5R)-5-acetamido-2-carboxy-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxan-2-yl]oxy-1,3-dihydroxypropyl]-2-carboxy-4-hydroxyoxan-2-yl]oxy-1,3-dihydroxypropyl]-2-carboxy-4-hydroxyoxan-2-yl]oxy-6-[(2R,3S,4R,5R,6R)-6-[(2S,3R)-2-(hexadecanoylamino)-3-hydroxyoctadecoxy]-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-5-hydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)-3-(2-oxopropyl)oxan-4-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

0
References

0
Patents

2392.152 Da
Monoisotopic Mass

-3.4
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 2393.1593 463.1
[M+Na]+ 2415.1412 467.2
[M+NH4]+ 2410.1858 468.6
[M+K]+ 2431.1152 450.6
[M-H]- 2391.1447 467.5
[M+Na-2H]- 2413.1267 483.6
[M]+ 2392.1515 470.0
[M]- 2392.1525 470.0
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.